chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial Covid on 04May; Initial Covid on 04May; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received BNT162b2 (BNT162B2), on 18Mar2021 at 12:00 as dose 1, single (Lot number: EN6206), in right arm, on 04Apr2021 at 12:00 as dose 2, single (Lot number: EW0151), in right arm, on 11Oct2021 at 12:00 as dose 3 (booster), single (Lot number: 30130BA), in right arm and on 14Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FK9893) at the age of 59 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 04May2022, outcome "unknown", COVID-19 (medically significant) with onset 04May2022, outcome "not recovered" and all described as "Initial Covid on 04May". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16May2022) Positive; (04May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Paxlovid rebound: Initial Covid + on 04May2022 and began Pax regiment same day; no symptoms by 07May2022 Rebound symptoms begin 14May2022  all cold like symptoms but stronger than original symptoms on 03May, 04May, 05May home test still + on 16May Symptoms still exist as of this writing report on 18May.  No follow-up attempts are possible. No further information is expected
grandma called pt has fever 105.7;given APAP instructed to given more APAP&warm sponge bath to cool skin;directed to go to ER;had fever/vomiting through the noc some mild viral sx;1/2hr later still t104 instructed to go to urgent care;
positive covid test; positive covid test; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 03Feb2022 as dose 4 (booster), single (Lot number: FJ1614) at the age of 65 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 25Jan2021 as dose 1, single (Lot number: 032L20A), on 22Feb2021 as dose 2, single (Lot number: 022M20A) and on 13Aug2021 as dose 3 (booster), single (Lot number: 026D21A) for covid-19 immunisation. The patient's relevant medical history included: "systemic sarcoidosis" (unspecified if ongoing); "cardiomyopathy" (unspecified if ongoing). Concomitant medication(s) included: CELLCEPT [MYCOPHENOLATE MOFETIL], start date: Jun2018, stop date: 15Jun2022; HUMIRA, start date: Jul2019, stop date: 15Jun2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Jun2022, outcome "not recovered" and all described as "positive covid test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Jun2022) Positive, notes: positive at home COVID test 7 days after COMPLETING 5 day course of paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: The reported Covid 19 positive after both the doses of COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
(Day 2) Cellulitis like symptoms - redness entire arm to elbow starting at injections location - swelling and extremely sore and hot to touch, spreading around arm. Day 3 spread around arm. Dr. prescribed 3 day dose of cephalexin 500 mg 4 times a day. Slight fever off and on.
Delayed onset of fever. The day after the vaccination (3/25), I felt feverish. 11 am 101.3 fever 11:24 am took aspirin 3:40 pm 100.5 fever
Light arm pain began an hour and half after injection. The following day, arm pain was increased  preventing movement of above shoulder, but not preventing  daily actives and not pain medication used. Skin raised around injection sight. Throughout that day increased tiredness and  fatigue was experienced but did not prevent from completing work at  the office. Two days after injection, arm pain remained the same as the day before and some tiredness experienced.  Skin red and raised in a 2in radius around injection site. Third day after injection, arm pain reduced, redness gone away.  No pain by the fifth day.  7 days after injection, skin is still raised around injection site, redness returned and is now itchy, and increased tiredness.
Hospital Course and Significant Findings: Patient is a 65 Y male with acute cholecystitis (with thickened gallbladder wall) and COVID+ managed non-operatively. Resolved with antibiotics and being discharged in good condition to complete 2 weeks course of antibiotics - vantin/flagyl for home. Advised to stick to low fat diet. Will need plans for interval lap chole in about 6-8 weeks.
After receiving vaccination patient was alert and talking.  About a minute after the vaccination patient got to his feet and was walking and talking.  About a minute later patient said he felt dizzy and had a syncopal episode which lasted about 15-20 seconds.  Patient was caught before he fainting and sustained no injury.  Patient was able to walk with assistance to an exam table where he was given a icy pop to eat, a cold pack for his head/neck, and his feet were elevated.  Patient was able to leave the office about 15 minutes later, complaining only of a mild headache.
She is currently experiencing arm ache; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer reported for self. This female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on an unspecified date for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient was asking if it's okay to take ibuprofen (ADVIL) after the 1st dose. She was currently experiencing arm ache. The outcome of event was unknown.   Information on the lot/batch number has been requested.
pt devel itchiness & wheals eruption-urticaria was given DPH by ER physician @ hosp
No symptoms after the vaccination on the day of or the day after getting the vaccine.  Two days after the vaccine, while at orthopedist (for a Rotator Cuff Surgery), I began to feel dizzy.  I sat down for a few minutes, drank some water, and then resumed my therapy.  After the first set of my 4th exercises I began to get dizzy, I sat down on the PT table, then laid down and fainted for about 1-2 seconds.  My blood pressure plummeted to 60/?. EMT?s and an ambulance were called.  I was given an IV and taken to hospital.  In the ER, my blood pressure elevated to 205/121. (I think that was it.)  I was given a cat scan, ekg, chest X-ray, blood tests, etc.  All tests were normal except a very slight (by one number)  magnesium level.  I was admitted for observation and more tests where performed.  My blood pressure remained high, but I had no more dizziness or syncope.  I was given many more blood tests, imagining, ultrasound of heart, ultrasound of carotid arteries,  ultrasound ?bubble test,? nuclear heart treadmill stress test.  All tests were normal.  The only change in my health that can be attributed to this episode is the Covid vaccine.
Blurred vision; Couldn't swallow very well; Sick after vaccination; Weird back pain; Back of legs on calves hurt; Rapid heartbeat; Swollen Thyroid; headache; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurred vision), DYSPHAGIA (Couldn't swallow very well), VACCINATION COMPLICATION (Sick after vaccination), BACK PAIN (Weird back pain) and PAIN IN EXTREMITY (Back of legs on calves hurt) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Systemic lupus erythematosus and Rheumatoid arthritis.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VISION BLURRED (Blurred vision) and DYSPHAGIA (Couldn't swallow very well). In March 2021, the patient experienced VACCINATION COMPLICATION (Sick after vaccination), BACK PAIN (Weird back pain), PAIN IN EXTREMITY (Back of legs on calves hurt), HEART RATE INCREASED (Rapid heartbeat), GOITRE (Swollen Thyroid) and HEADACHE (headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 13-Mar-2021, VISION BLURRED (Blurred vision) and DYSPHAGIA (Couldn't swallow very well) had resolved. At the time of the report, VACCINATION COMPLICATION (Sick after vaccination), BACK PAIN (Weird back pain), PAIN IN EXTREMITY (Back of legs on calves hurt), HEART RATE INCREASED (Rapid heartbeat), GOITRE (Swollen Thyroid) and HEADACHE (headache) outcome was unknown. Not provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.  Treatment medication details include beta blocker.
pt recvd vax 1130AM & 4PM started crying, high pitched screaming for 2 days; ran low grade fever which would shoot up to 102 then down again; a/screaming startes pt was very sleepy; 7 days p/was fussy crying all the time; blank stare; red
Received the Flu shot and Covid vaccine on left arm on the same day (12/08/2022). Had a constant pain, discomfort, stiffness and aching in the arm and shoulder since day one after the injection. Besides the pain, developed issues with limited range of motions in the arm and occasional pins and needles in the fingers after a few weeks. The pain got worse especially at nights, so I saw an orthopedic surgeon on 03/17/2023. Was diagnosed with post vaccine rotator cuff tendinopathy and subacromial bursitis. On the same day I did X-ray imaging of my shoulder and neck (finding: down sloping lateral acromion may contribute to rotator cuff impingement syndrome). My doctor ordered 8 weeks of physical therapy, for twice a week. Started my PT from 03/21/2023 for twice a week. I still had a lot of pain and limited range of motions. I couldn?t sleep at nights due to having lots of pain, so my doctor ordered an MRI. I did the MRI on 05/04/2023. The result came back with three findings: mild tendinopathy of the supraspinatus and subscapularis tendons, synovitis in the rotator interval which can be seen in frozen shoulder syndrome, a trace amount of fluid in the subacromial subdeltoid bursa. I had a follow up appointment with my doctor on 05/17/2023. Based on the current situation and persistent pain she suggested to do a Cortisone shot on the same day. She also suggested to continue with the physical therapy sessions. Since the injection, my constant pain got better specially at nights. But I still have a lot of pain when doing specific motions with my hand during physical therapy and also during normal routine, specifically raising my hand or reaching to some positions is with a lot of pain and in some cases impossible.  I am still doing my physical therapy sessions. My follow up appointment with my doctor is on 07/19/2023 (I?m seeing her every other month).
Initial report received from a healthcare professional on 19 March 2013. A 35-year-old female patient had received first dose of ADACEL vaccine (lot number: U4431AA, site of vaccination was not reported) intramuscularly on 19 March 2013. The patient's last menstrual period was on 20 August 2012. The patient's estimated date of delivery was reported as 27 May 2013. The patient's health during pregnancy, concomitant medications, medical history and risk factors were reported as "not applicable". As of 19 March 2013, the patient had not experienced any adverse events. As of 19 March 2013, the patient's outcome was unknown. Documents held by sender: none.
Beginning April 20, 2021 I experienced numbness, tingling and prickling sensations in my extremeties:  Both feet, ankles, all toes, and both hands and all fingertips.  As of today's date (6/26/21) the symptoms have dissipated somewhat but are not completely gone from any of the above mentioned areas.
Severe pain starting at top of left shoulder going half way down left arm. Redness and swelling size if fist. Blisters inside the redness. Pt treated with Benadryl and Hydrocortisone cream. Symptoms are improving
01/18/22 presents for "worsening dyspnea". PMHx of "PMH asthma, CHF, CAD s/p MI and stent"
chills, body aches, fever (99) Narrative:  patient took ibuprofen
GAVE MONOVALENT INSTEAD OF BIVALENT. 0 TREATMENT, OUTCOME WITHOUT SIGNS OR SYMPTOMS OF ADVERSE EFFECT
had Pfizer COVID-19 vaccine and flu shot to left arm and complained of left arm pain; had Pfizer COVID-19 vaccine and flu shot to left arm and complained of left arm pain; had Pfizer COVID-19 vaccine and flu shot to left arm and complained of left arm pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 28Sep2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 65 years intramuscular, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 28Sep2022 as dose number unknown, single (Batch/Lot number: unknown) intramuscular, in left arm; treprostinil sodium (TYVASO), since 13Jul2022 (Lot number: 2102217, Expiration Date: 31Dec2024) at 54 ug 4x/day for pulmonary arterial hypertension. The patient's relevant medical history included: "Pulmonary arterial hypertension" (ongoing). The patient's concomitant medications were not reported. The following information was reported: PRODUCT USE ISSUE (non-serious), OFF LABEL USE (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 28Sep2022, outcome "unknown" and all described as "had Pfizer COVID-19 vaccine and flu shot to left arm and complained of left arm pain". The action taken for treprostinil sodium was unknown. Therapeutic measures were taken as a result of pain in extremity.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up approximately around 1:30 a.m. with chills. Got up to get ready for work and felt slightly achy so I took my temp and it read 100.6.  I ate a piece of toast and took one 500 mg tablet of a Tylenol and went to work but was sent home due to the fever after getting home my aches kept getting worse I developed a headache and my temp fluctuated all day between 99 3 and got as high as 101.7 bye the afternoon. When I went to bed around 10 p.m. my temp had dropped to 99 but my upper lip felt puffy and was slightly swollen. When I got up the next morning at approximately 6 a.m. my upper lip was still swollen and my right cheekbone very was very tender to the touch. Upon submitting this report it is approximately 1:15 Eastern Standard Time and my lips are mostly back to normal but around my mouth is very tender and to my right cheek bone is still very tender to the touch. Other than that headaches are gone fever is gone and I overall feel pretty good.
Pt. states that after receiving the 2nd dose of Phizer 03/25/2021, started experiencing symptoms 04/08/2021 of leg pain (Sciatica). Primary visit diagnosed with Sciatica no other recommendations. Pt. still experiencing symptoms.
tested positive for COVID on 07Jan2021 which was two days before my second dose; tested positive for COVID on 07Jan2021 which was two days before my second dose; This is a spontaneous report from a contactable patient. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 19Dec2020 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received her Pfizer vaccine dose 1 on 19Dec2020. She tested positive for COVID on 07Jan2021 which was two days before her second dose of the vaccine. Her hospital was not sure whether she need just a second dose of the vaccine or if she should start the process over. Patient look forward to hearing your guidance on this matter. The outcome of the events was unknown.  Information on lot/ batch number has been requested.
sugar levels went very low; itchiness on injection site; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), BLOOD GLUCOSE DECREASED (sugar levels went very low) and VACCINATION SITE PRURITUS (itchiness on injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D13L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm) and VACCINATION SITE PRURITUS (itchiness on injection site). On an unknown date, the patient experienced BLOOD GLUCOSE DECREASED (sugar levels went very low). At the time of the report, PERIPHERAL SWELLING (Swollen arm), BLOOD GLUCOSE DECREASED (sugar levels went very low) and VACCINATION SITE PRURITUS (itchiness on injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: low (Low) Low.         Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2021: Added a new event (blood glucose decreased).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt. had a stroke on 6/7/2021,   The date of the J and J vaccination was 5/26. Incorrect date on first page.
1 week from last vaccine. I have broken out in rash to left area, severe itching to lower extremities  that even caused bruising. I have to till this day 5/3/21 have to take allergy tab every day. I week from last vaccine I have been menstruating since 4/6/21 was off for 1 week and back on today again with pelvic cramping, clots.
Patient given MENACTRA & ADACEL on 3-8-13. Mom reports 20 hrs after vaccine child had brief episode of trouble breathing. Mom gave BENADRYL, felt better.
Rash found on 1/24 above right eye, seen in ER on 1/25 with rash in vesicular form across forehead into hairline and across bridge of nose. Treatment: acyclovir 750 mg IV, prn acyclovir 800 mg po 5 x 1 day x 10 d,  Trifluridine ophth solution 2 dotts 5x/day, clindamycin 900 mg IV then d/c due to unable to tolerate, hydrocodone (APAP) prn, cephalexin 500 mg  PO BID x 7 d.
Dizzy; Body aches and pains/ sore all over; Headache; Sore arm; Chills; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 12:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), trazodone hydrochloride (DEPRAX) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and statin (MANUFACTURER UNKNOWN all were from an unknown date for unknown indications and unknown if on going. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Mar2021 at 12:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient previously took pneumococcal vaccine and experienced allergy to vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient underwent SARS-CoV-2 test and the result was negative. On 13Apr2021 at 14:30, the patient experienced dizzy, body aches and pains, headache, sore arm, sore all over, chills and joint pain. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of dizzy, body aches and pains, headache, sore arm, sore all over, chills and joint pain were not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained
Received shot of FLUVIRIN 0.5 mL on 9/17/12 at 5:30 P.M. On 9/20/12 had appt. w/primary care physician. My arm at the site was tender but by Sat. up to present I have been in severe pain.
Patient received first dose of RVS and vomited twice, second dose and subsequent doses were held.
dose administed 1 day after expiration date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administed 1 day after expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administed 1 day after expiration date). On 26-Jul-2021, EXPIRED PRODUCT ADMINISTERED (dose administed 1 day after expiration date) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported  No Treatment medications were reported
widespread itching, localized itching at injection site, swelling/welting at injection site, red area about the size of an orange around injection site, darkened discoloration like bruising persisting 2 weeks following first inection .  Reported to Employee Health